Idenix Pharmaceuticals (IDIX)

[DewDiligence]

>…I don't think it matters, except possibly in the limited case of pregnant patients, where treatment with Tyzeka would be preferred , even if the intent was to switch to something else after delivery.<

I disagree strongly with respect to the Tyzeka vs Hepsera comparison. There, the efficacy so strongly favors Tyzeka that other considerations ought not to matter.

For the Tyzeka vs Baraclude comparison, efficacy is sufficiently similar that the other considerations do matter. Tyzeka has a clear edge with pregnant patients and HIV-infected patients (which you forgot to mention in your latest post). For the general patient group (not pregnant, no HIV), I think it boils down to the question I asked in bold-face type in msg #1393.